IGF2BP1 and hematopoietic and lymphoid system neoplasm: It is noteworthy that the tumorigenic driving effect of IGF2BP1 in leukemia is predominantly regulated through non-m6A-dependent mechanism, according to a large number of papers related to hematologic tumors.